← Insider buys
ROIV

Roivant Sciences Ltd. · Healthcare

10% owner Vivek Ramaswamy sold $33.1M of Roivant Sciences Ltd.

Sold$33,150,000
$11.05Price
3,000,000Shares
−5%Stake

What ROIV did after the filing

Filed Jan 3Copier in Jan 4
The stock from Thu, Jan 4 open, $10.86
+6.7%
S&P 500, same days
+6.7%

Measured over 30 trading days, to the Feb 16 close.

Traded Tue, Jan 2. Filed Wed, Jan 3, 4:56 PM ET, after the close. Returns use the Jan 4 open and the Feb 16 close. Not investment advice.